ArticleCancer medicine2022

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer.

Benjamin Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.